Mandatory advance review of theses in medicine and pharmaceutics.


The mandatory advance review of all theses in the Disciplinary Domain of Medicine and Pharmacy will be introduced for public defences taking place after 1 January 2014, in accordance with the decision by the Disciplinary Domain Board of 13-06-2013.

The mandatory advance review is being introduced in order to secure the subject quality of theses in medicine and pharmaceutics at Uppsala University. It is important that the third-cycle courses and study programmes of the disciplinary domain maintain a high quality and a good reputation so that our doctors have the best opportunities for further research and professional careers. This is just as important for our ability to recruit the best students to our programmes. It is also important for us to be able to produce theses in medicine and pharmaceutics of a consistently high quality when our activities come under evaluation.

The application for public defence is to be submitted to the Committee for Third-Cycle Education 11 days before the meeting, so that it can be reviewed at least 12 weeks before the date of public defence. This is in accordance with previous procedures. View meeting dates and the closing dates for submission here: http://www.medfarm.uu.se/utbildning/forskarniva/for_doktorander/infor_lic_disp.html

What is new is that for all public defences after 1 January 2014; three examining committee members are to be appointed to participate in the advance review and public defence. However, it is possible to have five members, if so desired.

The Committee for Third-Cycle Education appoints the examining committee and coordinator for the advance review during their meeting. The Committee will then contact the examining committee members the following day. The examining committee has 10 working days from the date of their appointment by the Committee for Third-Cycle Education.

A coordinator for the advance review is appointed by the Committee for Third-Cycle Education, based on the proposal of supervisors in cases where the chair of the public defence is not a member of the examining committee. It is important that the supervisor informs the examining committee members already at the time of inquiry of the timetable for the advance review. The supervisor has the ultimate responsibility for ensuring that the advance review is submitted in time for a decision.

The application for public defence is raised again at the next meeting of the Committee for Third-Cycle Education, for a decision on whether the public defence may take place on the basis of the examining committee's recommendation. The decision is announced the day after the meeting. If the decision is negative, a new date of public defence may not be set closer than 3 months from the first date given.

The advance review adopts the use of “Instructions for advance review by the examining committee” and “Protocol for advance review by the examining committee”. The instructions and the protocol template are available under “Forms” http://www.medfarm.uu.se/utbildning/forskarniva/for_doktorander/blanketter.html.

Examining committee members receive these instructions in conjunction with being informed that the advance review is to take place. The protocol template is sent to the coordinator at the advance review. The coordinator certifies the result of the advance review with a signature and sends the protocol to the Office of Medicine and Pharmacy.